A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168
NCT05988021
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Interventions
DRUG:
CCX168
Sponsor
Amgen